Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
24,800
-150 (-0.60%)
At close: Aug 14, 2025, 3:30 PM KST
-0.60%
Market Cap172.83B
Revenue (ttm)69.65B
Net Income (ttm)15.30B
Shares Out6.97M
EPS (ttm)2,244.75
PE Ratio11.05
Forward PEn/a
Dividend1,500.00 (6.05%)
Ex-Dividend DateDec 27, 2024
Volume6,232
Average Volume20,511
Open24,950
Previous Close24,950
Day's Range24,600 - 25,000
52-Week Range14,500 - 31,450
Beta-0.29
RSI48.14
Earnings DateAug 14, 2025

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.